A Focus on the First 1,000 Days
Starting at conception, the health of both mother and child are of utmost importance. At Astarte Medical, we view the first 1,000 days as a window of opportunity to deliver solutions that allow hospitals and clinical teams to standardize care protocols and customize treatment plans, at a time that has a profound impact on long-term health.
These first 1,000 days are especially critical for preterm infants, who are facing significant challenges, which include:
Growth
Failure
Allergy, Asthma
and Obesity
Neurodevelopmental
Delays or Disabilities
Partnering with March of Dimes
Core to Astarte Medical is our comprehensive and proprietary dataset, which integrates feeding protocols, microbiome profiles and clinical information. Our NICUtrition® suite of products provides actionable information in real time to hospitals and clinical teams, enabling them to standardize care protocols and optimize nutrition.
LEARN MORE
Astarte Medical is pleased to join NEC Society’s community of leaders to champion a world without NEC.
NEC Society does not endorse any product or company, and does not create, sponsor, or authorize the content of any communications, surveys, programs, or incentives from any company. NEC Society is a registered word mark of its owner, and its use does not imply any affiliation, endorsement, or sponsorship by them.
About Astarte Medical
Led by a distinguished team and world-class advisors in neonatology, nutrition and microbiome, Astarte Medical is the only precision nutrition company using software and predictive analytics to improve outcomes during the first 1,000 days of life, with an initial focus on preterm infants.
Featured News
Astarte Medical is Lead Sponsor of Thanksgiving Meal Project
Astarte Medical Selected to Exhibit NICUtrition® at Vizient Innovative Technology Exchange
Astarte Medical is one of eight pediatric-focused digital health companies invited to participate in the 2022 KidsX Accelerator